Impulsive decision‐making is characterized by actions taken without considering consequences. Patients with Parkinson's disease (PD) who receive dopaminergic treatment, especially dopamine agonists, are at risk of developing impulsive–compulsive behaviors (ICBs). We assessed impulse‐related changes across a large heterogeneous PD population using the Barratt impulsivity scale (BIS‐11) by evaluating BIS‐11 first‐ and second‐order factors.

中文翻译：

---

帕金森病患者自我报告的冲动率。


冲动决策的特点是不考虑后果而采取行动。接受多巴胺能治疗（尤其是多巴胺激动剂）的帕金森病（PD）患者有发生冲动强迫行为（ICB）的风险。我们通过评估 BIS-11 一阶和二阶因素，使用 Barratt 冲动量表 (BIS-11) 评估了大量异质性 PD 人群的冲动相关变化。